Name: Latest research reports of Sun Pharmaceutical Industries Ltd. authored by Motilal Oswal and published by - Trendlyne research reports.
Item: Sun Pharmaceutical Industries Ltd.
Rating: 5
Author: Motilal Oswal

Summary	Date	Stock	Author	LTP	Target	Price at reco (Change since reco%)	Upside(%)	Type	Report	Discuss
	13 Sep 2025	Sun Pharmaceutical	Consensus Share Price Target	1616.60	1930.16	-	19.40	buy	pdf Detailed Estimates
	31 Jan 2023	Sun Pharmaceutical	Motilal Oswal Target	1616.60	1220.00	1034.50 (56.27%)	Target met	Buy	pdf post cache	Broker Report Specialty sales remains encouraging Motilal Oswal pdf Copy Link Share on Share on Share on Share on Alert
	19 Jan 2023	Sun Pharmaceutical	Motilal Oswal Target	1616.60	1200.00	1040.55 (55.36%)	Target met	Buy	pdf post cache	Broker Report Concert deal paves way to add JAK inhibitors to specialty portfolio Motilal Oswal pdf Copy Link Share on Share on Share on Share on Alert
	10 Nov 2022	Sun Pharmaceutical	Geojit BNP Paribas Reco Target	1616.60	1078.00	1013.55 (59.50%)	Target met	Hold	pdf post cache	Broker Report SUN PHARMA Geojit BNP Paribas pdf Copy Link Share on Share on Share on Share on Alert
	03 Nov 2022	Sun Pharmaceutical	SMC online	1616.60		1039.90 (55.46%)		Results Update	pdf post cache	Broker Report Sun Pharmaceuticals Industries SMC online pdf Copy Link Share on Share on Share on Share on Alert
	02 Nov 2022	Sun Pharmaceutical	ICICI Direct Target	1616.60	1225.00	1051.95 (53.68%)		Buy	pdf post cache	Broker Report Sun Pharma ICICI Direct pdf Copy Link Share on Share on Share on Share on Alert
	02 Nov 2022	Sun Pharmaceutical	Prabhudas Lilladhar Target	1616.60	1175.00	1044.20 (54.82%)		Buy	pdf post cache	Broker Report SUN PHARMACEUTICAL I Prabhudas Lilladhar pdf Copy Link Share on Share on Share on Share on Alert
	02 Nov 2022	Sun Pharmaceutical	Motilal Oswal Target	1616.60	1240.00	1051.95 (53.68%)		Buy	pdf post cache	Broker Report Another quarter of an earnings beat Motilal Oswal pdf Copy Link Share on Share on Share on Share on Alert
	02 Nov 2022	Sun Pharmaceutical	ICICI Securities Limited Target	1616.60	1002.00	1036.60 (55.95%)	Target met	Hold	pdf post cache	Broker Report Specialty business grows; margins expand ICICI Securities Limited Sun Pharmaceutical’s (Sun) Q2FY23 performance has been better than our estimates. pdf Copy Link Share on Share on Share on Share on Alert
	01 Nov 2022	Sun Pharmaceutical	BOB Capital Markets Ltd. Reco	1616.60	1100.00	1051.95 (53.68%)	Target met	Hold	pdf post cache	Broker Report Sun Pharma (HOLD): Strong Q2 but valuations full cut to HOLD BOB Capital Markets Ltd. Brisk Q2 revenue growth at 14% YoY to Rs 110bn backed by ramp-up in global specialty business and healthy India/EM sales pdf Copy Link Share on Share on Share on Share on Alert
	01 Nov 2022	Sun Pharmaceutical	Bonanza	1616.60	1072.00	1036.60 (55.95%)	Target met	Buy	pdf post cache	Broker Report STRATEGY: TECHNICAL RESULT PREVIEW Q2 FY23 Bonanza Given that there are good chances of breakout on both the sides but down side is normally remained limited in Sun Pharma historically. pdf Copy Link Share on Share on Share on Share on Alert
more loading

Near 52W Low of ₹1553.05

Sun Pharmaceutical Industries Ltd. share price target

Sun Pharmaceutical Industries Ltd. has an average share price target of 2050.25. The consensus estimate represents an upside of 26.82% from the last price of 1616.60. View 14 reports from 8 analysts offering long-term price targets for Sun Pharmaceutical Industries Ltd..

Specialty sales remains encouraging

Concert deal paves way to add JAK inhibitors to specialty portfolio

SUN PHARMA

Sun Pharmaceuticals Industries

Sun Pharma

SUN PHARMACEUTICAL I

Another quarter of an earnings beat

Specialty business grows; margins expand

Sun Pharma (HOLD): Strong Q2 but valuations full cut to HOLD

STRATEGY: TECHNICAL RESULT PREVIEW Q2 FY23

Advisor Screeners